| P2093 | author name string | Mahesh V Chaubal | |
| P2860 | cites work | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 |
| | The price of innovation: new estimates of drug development costs | Q28212140 |
| | Combinatorial compound libraries for drug discovery: an ongoing challenge | Q30310572 |
| | Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. | Q30482391 |
| | Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance | Q30790128 |
| | Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis | Q30828426 |
| | Drug discovery by dynamic combinatorial libraries | Q31096767 |
| | Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships | Q31152324 |
| | Pharmacological effects of formulation vehicles : implications for cancer chemotherapy | Q33187648 |
| | An automated approach to salt selection for new unique trazodone salts | Q33198636 |
| | Role of the development scientist in compound lead selection and optimization | Q33846122 |
| | In vitro assessment of oral lipid based formulations | Q34384372 |
| | Integration of virtual and high-throughput screening | Q34988235 |
| | Nanosizing: a formulation approach for poorly-water-soluble compounds | Q35069024 |
| | Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 |
| | Solid Dispersions: Revival with Greater Possibilities and Applications in Oral Drug Delivery | Q35570640 |
| | Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine | Q40544594 |
| | Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens | Q44247751 |
| | Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography/mass spectrometry | Q44268458 |
| | Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors | Q44558783 |
| | A high-throughput combinatorial approach for the discovery of a cremophor EL-free paclitaxel formulation | Q44568350 |
| | Potential Use of Cyclodextrins to Enhance the Solubility of YM466 in Aqueous Solution | Q44626163 |
| | Synthesis and Evaluation of PEG414, a Novel Formulating Agent that Avoids Analytical Problems Associated with Polydisperse Vehicles such as PEG400 | Q44645946 |
| | Brain uptake of thiamine-coated nanoparticles | Q44673525 |
| | Lead optimization in 12 months? True confessions of a chemistry team | Q47574636 |
| | Ultra-long-duration local anesthesia produced by injection of lecithin-coated tetracaine microcrystals. | Q51632319 |
| | Prediction of aqueous solubility of organic compounds using a quantitative structure-property relationship. | Q52036817 |
| | Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs | Q71809729 |
| | An intravenous formulation decision tree for discovery compound formulation development | Q73019454 |
| | An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization | Q73304068 |
| | When can cyclodextrins be considered for solubilization purposes? | Q73311335 |
| | An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment | Q74460680 |
| | Biopharmaceutics classification system: the scientific basis for biowaiver extensions | Q74614652 |
| P433 | issue | 14 | |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 603-609 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Application of drug delivery technologies in lead candidate selection and optimization | |
| P478 | volume | 9 | |